{
    "title": "109_hr3423",
    "content": "The Act titled \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees for fiscal years 2005, 2006, and 2007. The Medical Device User Fee Stabilization Act of 2005 adjusts device user fees for fiscal years 2005, 2006, and 2007. Changes include increasing fees to $259,600 and allowing the Secretary to use unobligated carryover balances for fiscal years 2006 and 2007. Notification to Congress is required before using these funds. The Medical Device User Fee Stabilization Act of 2005 amends small business definitions and fee amounts for fiscal years 2005, 2006, and 2007. The definition of a small business is now an entity with $30,000,000 or less in gross receipts. Fee amounts are increased to $100,000,000 in various subsections. The Medical Device User Fee Stabilization Act of 2005 adjusts performance goals and funding requirements for fiscal year 2005. The Secretary must meet performance goals if the appropriated amount is equal to or greater than $205,720,000 multiplied by the adjustment factor. If the appropriated amount is more than 1 percent less, specific conditions apply. The Medical Device User Fee Stabilization Act of 2005 amends performance goals and funding requirements for fiscal year 2005 by making specific adjustments. The Medical Device User Fee Stabilization Act of 2005 makes amendments to performance goals and funding requirements for fiscal year 2005, including changes to terminology and reporting requirements for fiscal years 2006 and 2007. The report required for fiscal year 2005 includes information on types of applications, fees paid by businesses in different revenue categories, and a certification by the Secretary regarding funding for FDA expenses. Amendments are made to the definition of misbranded devices in the Federal Food, Drug, and Cosmetic Act. The Cosmetic Act is amended to require reprocessed single-use devices to bear the manufacturer's name, abbreviation, or symbol. Reprocessed devices without this information must have a detachable label on the packaging. The Secretary of Health and Human Services will issue guidance on identifying manufacturer information for original devices. The FDA will issue guidance on identifying manufacturer information for original devices, ensuring that the name, abbreviation, or symbol is prominently displayed. Effective dates for device labeling requirements are specified in the Medical Device User Fee Modernization Act. The FDA will issue guidance on displaying manufacturer information on original devices, with specific effective dates for device labeling requirements under the Medical Device User Fee Modernization Act. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}